Cargando…
Tumor-Treating Fields Inhibit the Metastatic Potential of Osteosarcoma Cells
The prognosis of metastatic osteosarcoma (OS) remains poor with a <20% survival rate, particularly in cases of distant (non-lung) metastases. Tumor-treating field (TTF) therapy is a novel electric field-based treatment that causes metaphase arrest and tumor cell death, with the advantage of reduc...
Autores principales: | Oh, Ju Yeon, Lee, Yeon-Joo, Kim, Eun Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502799/ https://www.ncbi.nlm.nih.gov/pubmed/32938326 http://dx.doi.org/10.1177/1533033820947481 |
Ejemplares similares
-
Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells
por: Lee, Hye Eun, et al.
Publicado: (2019) -
5-Fluorouracil as a Tumor-Treating Field-Sensitizer in Colon Cancer Therapy
por: Lee, Yeon-Joo, et al.
Publicado: (2019) -
The Unfolded Protein Response: Neutron-Induced Therapy Autophagy as a Promising Treatment Option for Osteosarcoma
por: Oh, Ju Yeon, et al.
Publicado: (2020) -
Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells
por: Oh, Ju Yeon, et al.
Publicado: (2019) -
Gene expression profiling of glioblastoma cell lines depending on TP53 status after tumor-treating fields (TTFields) treatment
por: Lee, Yeon-Joo, et al.
Publicado: (2020)